Table 3.
Variables | Odds Ratio (95%CI) of Increased uACR by LAPI LAPI Quartiles | P-value for Trend | P for Interaction | |||
---|---|---|---|---|---|---|
Q1 | Q2 | Q3 | Q4 | |||
UACR ≥30 mg/g | ||||||
Gender | 0.511 | |||||
Men | 1.00 | 1.03 (0.77–1.38) | 0.69 (0.58–1.05) | 1.31 (0.95–1.79) | 0.052 | |
Women | 1.00 | 1.12 (0.94–1.33) | 1.29 (1.08–1.53)* | 1.48 (1.23–1.79)* | <0.001 | |
Age, years | 0.395 | |||||
<60 | 1.00 | 1.06 (0.88–1.28) | 1.21 (1.01–1.46)* | 1.47 (1.20–1.79)* | <0.001 | |
≥60 | 1.00 | 1.02 (0.78–1.34) | 0.89 (0.68–1.17) | 1.09 (0.82–1.45) | 0.227 |
Notes: *Significance of Pvalue (P<0.05). Adjusted for BMI; DM family; drinking; smoking; SBP; DBP; HDL; FBG; PBG; HbA1c.
Abbreviations: uACR, urinary albumin to creatinine ratio; eGFR, estimated glomerular filtration rate; LAP, lipid accumulation product index; eGFR BMI, body mass index; DM, diabetes mellitus; CVD, cardiovascular disease; HDL, high-density lipoprotein cholesterol; FBG, fasting blood glucose; PBG, 2-h postload blood glucose; HbA1c, glycosylated hemoglobin.